41 reports

  • Musculoskeletal Drugs was the largest segment in the region market at 15.5% of the market worth about $6.4 billion.

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • Respiratory Monitoring
  • Market Size

Students are also demonstrated the examination of gastrointestinal endoscopy.

  • Healthcare
  • Managed Care
  • Medical Education
  • World
  • Market Size

ORAL MEDICATIONS THAT INCLUDE ANTIBIOTICS AND RETINOIDS HAVE LED TO INCREASED HEPATOTOXICITY, GASTROINTESTINAL ISSUES AND SUICIDAL TENDENCIES, ALONG WITH THE ABOVE MENTIONED ISSUES.

  • Dermatological Treatment
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.
  • ATRIPLA SWOT ANALYSIS, 2016

BIOSCIENCE TRENDS; ##(##): ##-##.

  • Hepatitis Treatment
  • Managed Care
  • East Asia
  • Gilead Sciences, Inc.
  • ViiV Healthcare Ltd.

Genotype ## is the most common HCV.

  • Dermatological Treatment
  • Hepatitis Treatment
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson

Scope of Business: ##.

  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • China
  • Xian-Janssen Pharmaceutical Ltd.

We are one of the nation' s Top ## health systems.

  • Managed Care
  • United States
  • Company
  • Supply
  • GlobalData's company

Scope of Business: ##.

  • Dermatological Treatment
  • Hepatitis Treatment
  • China
  • Novartis AG
  • Xian-Janssen Pharmaceutical Ltd.

Systemic tetracycline may cause gastrointestinal upset, nausea, diarrhea, and vaginal yeast infection.

  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • Allergan plc
  • Galderma S.A.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation

Elvitegravir inhibits HIV-## integrase.

  • Dermatological Treatment
  • Hepatitis Treatment
  • United States
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.

B-## Table of Contents iv U. S.

  • Dermatological Treatment
  • Managed Care
  • United States
  • Covidien plc
  • Smith & Nephew Plc
  • Clinical Trial profile. 187 Trial Title
  • Clinical Trial profile. 341 Trial Title

The prominent features of this report are - ##.

  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • Pharmaceutical
  • World
  • PRASCO LABS ENTERS INTO CO-MARKETING AGREEMENT WITH SHIRE FOR CARBATROL

GlobalData Prasco LLC, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Dermatological Treatment
  • Pharmaceutical
  • United States
  • M&A
  • Prasco, LLC
  • Dr Reddy's Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir
  • Dr Reddy's Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir

The drug candidate acts by inhibiting Gag protein (HIV-## Maturation Inhibitor).

  • Dermatological Treatment
  • Hepatitis Treatment
  • Therapy
  • India
  • Hetero Drugs Limited

This agreement enables Beactica to advance one of their prioritized discovery programmes and enables Medivir to search for hits active against one of its early discovery targets.

  • Hepatitis Treatment
  • Pharmaceutical
  • Therapy
  • Sweden
  • Medivir UK Ltd.
  • Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017

Deal Rationale Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products.

  • Clinic
  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • GlobalData's company
  • FRESENIUS MEDICAL CARE AG & CO KGAA, DEALS BY THERAPY AREA, 2012 TO YTD 2018

Dialysis treatments increased by ##%.

  • Healthcare
  • Managed Care
  • United States
  • Company Financials
  • Fresenius Group

One unit is one oximeter sensor.

  • Hepatitis Treatment
  • Managed Care
  • Respiratory Monitoring
  • Sensor
  • GlobalData's company
  • Geisinger Health System - History

In August, GHS established a new, US$##. ## million gastrointestinal suite, Geisinger Community Medical Center.

  • Healthcare
  • Managed Care
  • United States
  • Company
  • Geisinger Health System
  • Respiratory Measurement Devices Companies and Product Overview

One unit is one Capnograph.

  • Clinical Trial
  • Hepatitis Treatment
  • Hospital
  • Managed Care
  • Respiratory Monitoring

The molecules developed by Companies in Phase I, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Dermatological Treatment
  • Therapy
  • World
  • Product Initiative
  • Pfizer Inc.

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Cancer
  • Clinical Trial
  • Managed Care
  • United States
  • GlobalData's company
  • Pipeline by EA Pharma Co Ltd, H1 2018
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

Results from the Phase I study were presented at the 2017 Gastrointestinal Cancers Symposium.

  • Dermatological Treatment
  • Hospital
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • Pipeline by EA Pharma Co Ltd, H2 2017
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Cardiovascular Disease
  • Dermatological Treatment
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

The molecules developed by companies in Phase I, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Dermatological Treatment
  • Hospital
  • Therapy
  • World
  • Product Initiative

We grew faster than the market in ## out of our ## top therapies - Respiratory, Anti-infectives, Gastrointestinal and Urology.

  • Hepatitis Treatment
  • Pharmaceutical
  • India
  • Company
  • Cipla Ltd

PT/ ##:## p. m.

  • Clinical Trial
  • Managed Care
  • Point Of Care Testing
  • Rapid Test
  • Helena Laboratories Corporation

Parion Sciences develops ENaC blockers which are used to treat lung, mouth, nose and the gastrointestinal tract.

  • Clinical Trial
  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • Respiratory Monitoring

DEAL IN BRIEF PARTNER ##: NIKKISO CO., LTD.

  • Healthcare
  • Managed Care
  • United States
  • M&A
  • Fresenius Group